OTC: HGYN

HONG YUAN HOLDING GROUP

CIK 0001324759 · Materials · SIC 2821 · Plastics Materials & Resins

Micro Revenue $838K Assets $578K as of Aug 2, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (FISV 10-Q) is open in full — no account needed.

10-Q Filed Jun 22, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed May 8, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

Partner

Trade HGYN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jan 9, 2026 · Period ending Jan 7, 2026

Summary not yet generated.

10-Q Filed Nov 19, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q/A Filed Sep 26, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed Aug 19, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Jul 3, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

8-K Filed Mar 11, 2025 · Period ending Feb 26, 2025

Summary not yet generated.

8-K Filed May 14, 2024 · Period ending May 9, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Jun 22, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q1 ended Mar 31, 2026 Q3 ended Sep 30, 2025
Revenue:
Total revenue / net sales 43,697 258,329
Cost of revenue / cost of sales 21,712 80,318
Gross profit 21,985 178,011
Operating expenses:
Sales and marketing 16,968 16,933
General and administrative 67,235 67,256
Total operating expenses 116,552 122,241
Operating income (94,567) 55,770
Other income/(expense), net 96.00 34.00
Income before income taxes (94,471)
Net income (93,346) 48,622
Basic earnings per share (0.00)
Diluted earnings per share (0.00)

Consolidated Balance Sheets (Unaudited)

Description Mar 31, 2026 Dec 31, 2025
Current assets:
Cash and equivalents 6,444 16,747
Inventories 27,964 34,286
Prepaid expenses and other current assets 122,539 124,966
Other current assets 388,525 404,048
Total current assets 545,472 580,047
Property, plant and equipment, net 212.00 209.00
Operating lease right-of-use assets, net 5,872 9,987
Finite-lived intangible assets, net 15,797 9,492
TOTAL ASSETS 577,926 611,315
Current liabilities:
Current portion of operating lease liabilities 2,103 9,987
Income taxes payable 588.00 11,201
Deferred revenue, current 87,450 120,652
Other current liabilities 555,619 449,829
Total current liabilities 645,760 591,669
Operating lease liabilities 2,223
Total liabilities 647,983 591,669
Shareholders' equity:
Common stock 74,641 74,641
Capital in excess of stated value 97,471,393 97,471,393
Accumulated other comprehensive income (loss) 18,502 14,865
Retained earnings (deficit) (97,745,991) (97,652,645)
Total shareholders' equity (152,447) (62,738)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 577,926 611,315

Consolidated Statements of Cash Flows (Unaudited)

Description Q1 ended Mar 31, 2026 Nine months ended Sep 30, 2025
Operating Activities:
Net cash from operating activities (3,420) (28,822)
Investing Activities:
Net cash from investing activities (7,079) (5,540)
Financing Activities:
Net increase/(decrease) in cash (10,303) (33,681)

Amounts in USD as reported; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗